Tags

Type your tag names separated by a space and hit enter

[Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
Zhonghua Wai Ke Za Zhi. 2000 Oct; 38(10):767-70.ZW

Abstract

OBJECTIVES

To detect mutations of the K-ras codon 12 in DNA extracted from the plasma of patients with pancreatic cancer, and to explore the possibility of using this method in early diagnosis of pancreatic cancer.

METHODS

Plasma DNA was isolated from the blood of 22 patients with pancreatic cancer and from 20 normal controls. K-ras codon 12 mutations were detected by mutant enriched polymerase chain reaction-restriction fragment length polymorphism technique and subsequent product sequencing. The relation of K-ras mutations in plasma to clinical features in pancreatic cancer patients was analyzed.

RESULTS

Seventeen (77.3%) of 22 patients with pancreatic cancer had a codon 12 K-ras mutation in their plasma DNA. In two patients, the PCR products were sequenced and the mutations were confirmed. The occurrence of K-ras mutations in the plasma DNA was not related to tumor location, tumor size, and TNM stage. No K-ras mutation was detected in the plasma specimen of any of the normal controls.

CONCLUSIONS

K-ras mutations are frequently found in the plasma DNA of patients with pancreatic cancer. Analysis of K-ras mutation in the plasma DNA may be useful in the early detection of pancreatic cancer.

Authors+Show Affiliations

Department of Surgery, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Second Medical University, Shanghai 200025, China.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

chi

PubMed ID

11832160

Citation

Feng, D, et al. "[Detection of K-ras Gene Mutations in DNA Extracted From the Plasma of Patients With Pancreatic Cancer]." Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery], vol. 38, no. 10, 2000, pp. 767-70.
Feng D, Han T, Jiang Y, et al. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer]. Zhonghua Wai Ke Za Zhi. 2000;38(10):767-70.
Feng, D., Han, T., Jiang, Y., Yuan, Z., Wang, X., Jiang, Z., & Zhang, S. (2000). [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery], 38(10), 767-70.
Feng D, et al. [Detection of K-ras Gene Mutations in DNA Extracted From the Plasma of Patients With Pancreatic Cancer]. Zhonghua Wai Ke Za Zhi. 2000;38(10):767-70. PubMed PMID: 11832160.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer]. AU - Feng,D, AU - Han,T, AU - Jiang,Y, AU - Yuan,Z, AU - Wang,X, AU - Jiang,Z, AU - Zhang,S, PY - 2002/2/8/pubmed PY - 2005/8/24/medline PY - 2002/2/8/entrez SP - 767 EP - 70 JF - Zhonghua wai ke za zhi [Chinese journal of surgery] JO - Zhonghua Wai Ke Za Zhi VL - 38 IS - 10 N2 - OBJECTIVES: To detect mutations of the K-ras codon 12 in DNA extracted from the plasma of patients with pancreatic cancer, and to explore the possibility of using this method in early diagnosis of pancreatic cancer. METHODS: Plasma DNA was isolated from the blood of 22 patients with pancreatic cancer and from 20 normal controls. K-ras codon 12 mutations were detected by mutant enriched polymerase chain reaction-restriction fragment length polymorphism technique and subsequent product sequencing. The relation of K-ras mutations in plasma to clinical features in pancreatic cancer patients was analyzed. RESULTS: Seventeen (77.3%) of 22 patients with pancreatic cancer had a codon 12 K-ras mutation in their plasma DNA. In two patients, the PCR products were sequenced and the mutations were confirmed. The occurrence of K-ras mutations in the plasma DNA was not related to tumor location, tumor size, and TNM stage. No K-ras mutation was detected in the plasma specimen of any of the normal controls. CONCLUSIONS: K-ras mutations are frequently found in the plasma DNA of patients with pancreatic cancer. Analysis of K-ras mutation in the plasma DNA may be useful in the early detection of pancreatic cancer. SN - 0529-5815 UR - https://www.unboundmedicine.com/medline/citation/11832160/[Detection_of_K_ras_gene_mutations_in_DNA_extracted_from_the_plasma_of_patients_with_pancreatic_cancer]_ L2 - http://journal.yiigle.com/LinkIn.do?linkin_type=pubmed&issn=0529-5815&year=2000&vol=38&issue=10&fpage=767 DB - PRIME DP - Unbound Medicine ER -